Last reviewed Oct 21, 2026

Compounded semaglutide vs. the Wegovy pill

We may earn a commission from some links on this page. How we make money.

Short answer: Compounded semaglutide is not FDA-approved, and FDA doesn't review it for safety, effectiveness or quality before it's sold. It's usually a weekly injection. At the starting dose, the FDA-approved Wegovy pill costs about the same: $149 a month cash versus $133 to $190 a month for compounded semaglutide at one online program we checked. Compounded is cheaper at higher doses, especially on prepaid plans. Since the semaglutide shortage ended on Feb 21, 2025, FDA has tightened the rules on compounding copies and on how companies market them.

At a glance

	Wegovy pill	Compounded semaglutide
FDA-approved	Yes (Dec 22, 2025)	No
FDA reviews quality before sale	Yes	No
How you take it	Daily tablet	Typically a weekly injection, often drawn from a multi-dose vial
Trial evidence	13.6% average weight loss at 64 weeks (OASIS 4)	None for the compounded product itself
Cash price / month	$149 (1.5 mg), $199 (4 mg), $299 (9 and 25 mg)	Example: $190 month to month, or $99–$133/mo prepaid for 3–12 months*
Insurance savings card	As little as $25/mo if your plan covers it	Not applicable
Medicare GLP-1 Bridge ($50/mo)	Covered if eligible	Not covered

*HealthRX's published prices on Oct 20, 2026: $190 for one month, $399 for 3 months ($133/mo), $714 for 6 months ($119/mo), $1,188 for 12 months ($99/mo); subscription versions are slightly lower. Other sellers differ. Wegovy pill prices are NovoCare's self-pay prices.

What the first year costs

Wegovy pill, cash: about $3,338 for medication if you step up monthly on the label schedule ($149 + $199 + $299, then $299 × 9).
Compounded semaglutide, 12-month prepaid at the program above: $1,188, paid up front.
Wegovy pill with insurance that covers it: as little as $25 a month with Novo Nordisk's savings card. On Medicare and eligible: $50 a month through the GLP-1 Bridge.

So compounded can save about $2,150 in year one for cash payers who commit to a prepaid plan, and saves little or nothing if you have coverage or qualify for Medicare's Bridge.

Is compounded semaglutide legal in 2026?

It depends on how it's made and sold. While semaglutide was in shortage, compounders could make copies. FDA declared the shortage resolved on Feb 21, 2025, and the grace periods for copies ended in spring 2025. Under FDA's current policy (updated Apr 1, 2026):

A state-licensed (503A) pharmacy generally can't regularly compound "essentially a copy" of an approved drug: the same active ingredient, in a similar strength, given the same way.
The exception is when a prescriber determines and documents that a change makes a significant difference for an individual patient. FDA also says it doesn't intend to act against a pharmacy that fills four or fewer prescriptions of a copy in a month.
On Feb 6, 2026, FDA said it intends to restrict the GLP-1 ingredients used in non-approved compounded drugs, and warned companies it may take legal action without further notice.
On Mar 3, 2026, FDA announced warning letters to 30 telehealth companies over compounded GLP-1 marketing, including claims implying the products are the same as approved drugs.
On Apr 30, 2026, FDA proposed excluding semaglutide and tirzepatide from the list of substances large outsourcing (503B) facilities can compound from bulk.

For you as a patient, the practical point is that supply from any one compounded seller could change quickly.

Safety issues FDA has flagged

Dosing errors: FDA warned that confusion between milliliters, milligrams and "units" led some patients to inject 5 to 20 times the intended dose of compounded semaglutide, with some needing medical care or hospitalization.
Adverse event reports: as of Nov 30, 2024, FDA had received more than 392 reports for compounded semaglutide and more than 215 for compounded tirzepatide.
Salt forms: semaglutide sodium and semaglutide acetate are different active ingredients from the one in approved drugs, and FDA says it knows of no lawful basis for compounding with them.
Fakes: products labeled "for research purposes" or "not for human consumption" are not legitimate medicine.

Questions to ask before you buy compounded

Which pharmacy compounds it, and is it a state-licensed 503A pharmacy or an FDA-registered 503B outsourcing facility?
Is it semaglutide base, or a salt form (sodium or acetate)?
Will my dose be written in milligrams, with the syringe and volume spelled out?
What happens to my supply and refund if the pharmacy stops compounding it?

Red flags in an ad: "generic Wegovy," "same as Ozempic," "the same active ingredient," "FDA-approved pharmacy," or weight-loss percentages from brand-name trials. FDA has said compounded products can't be marketed as generic versions of, or the same as, FDA-approved drugs.

Our take

If cost is the reason you're looking at compounded, price the Wegovy pill or Foundayo first: both start at $149 a month cash, and coverage or Medicare can make them far cheaper. Compounded can cost less at higher doses for cash payers on prepaid plans, but you give up FDA review, and supply rules are in flux.

Wegovy pill price by dose →Where to get an FDA-approved pill

Want an FDA-approved option?

Ro and LifeMD both list the Wegovy pill and Foundayo, starting at $149 a month for the medication. Compare fees on our where-to-get page.

Ro →LifeMD →

FAQ

Is compounded semaglutide the same as Wegovy?

No. Compounded semaglutide is not FDA-approved, and FDA doesn't review compounded drugs for safety, effectiveness or quality before they're sold. FDA has said compounded products can't be marketed as generic versions of, or the same as, approved drugs.

Is compounded semaglutide cheaper than the Wegovy pill?

At the starting dose, not by much: the Wegovy pill is $149 a month cash, and one online program we checked charges $133 to $190 a month for compounded semaglutide. At higher doses, prepaid compounded plans can cost about half as much.

Is compounded semaglutide still legal in 2026?

It depends. Since the shortage ended on Feb 21, 2025, state-licensed pharmacies generally can't regularly compound copies of approved drugs unless a prescriber documents a significant difference for the patient. FDA has also announced plans to restrict GLP-1 ingredients used in compounding.

Is there a compounded semaglutide pill?

Some sellers have offered compounded oral versions, but no compounded version is FDA-approved, and FDA's dosing warnings involved injectable products. The only FDA-approved semaglutide pill for weight loss is the Wegovy pill.

Does Medicare cover compounded semaglutide?

No. The Medicare GLP-1 Bridge covers specific FDA-approved products: Foundayo, Wegovy injection or tablet, and Zepbound KwikPen.